+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Immunoglobulins Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Primary Immune Deficiency (PID) - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
From
From
From
Plasma Therapeutics Market 2024-2028 - Product Thumbnail Image

Plasma Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 147 Pages
  • Global
From
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Loading Indicator